Related Experiment Video
Updated: Jul 9, 2026

10:40
Visualization and Analysis of Blood Flow and Oxygen Consumption in Hepatic Microcirculation: Application to an Acute Hepatitis Model
Published on: August 5, 2012
Statistical study on fulminant liver disease in Japan
Summary
This study analyzed 1,000 autopsy cases of fulminant liver disease in Japan (1969-1978). The incidence of fulminant hepatic failure remained stable, with varied liver weights and frequent visceral complications.
Area of Science:
- Pathology
- Hepatology
- Forensic Medicine
Background:
- Fulminant liver disease is a critical condition with high mortality.
- Understanding its pathological characteristics is crucial for diagnosis and management.
- Autopsy data provides valuable insights into disease patterns.
Purpose of the Study:
- To analyze the clinicopathological features of fulminant liver disease.
- To determine the incidence and demographic distribution of fulminant hepatic failure.
- To identify associated pathological findings and complications.
Main Methods:
- Retrospective analysis of autopsy cases from Japan (1969-1978).
- Inclusion criteria: cases matching the pathological definition of fulminant liver disease.
- Statistical review of 1,000 selected cases out of 239,414 total autopsies.
Main Results:
- Fulminant liver disease accounted for 0.42% of autopsy cases.
- No significant chronological or geographical variations in incidence were observed in Japan.
- Patient age distribution was wide, with no sex predilection; a notable number were healthcare professionals.
- Liver weight was typically reduced, but hypertrophy occurred in some cases.
- Frequent complications included hemorrhage, acute inflammation, and necrosis in various organs.
Conclusions:
- Fulminant liver disease represents a consistent pathological entity in Japan.
- The findings highlight the diverse clinical presentations and frequent systemic complications.
- Autopsy data is essential for characterizing rare and severe hepatic conditions.
Related Concept Videos
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

